Mr. Hugh Rogers reports

BIONXT SOLUTIONS INC. ANNOUNCES CLOSING OF EXTENSION OF CONVERTIBLE DEBENTURES AND ISSUANCE OF WARRANTS

Bionxt Solutions Inc. has closed its previously announced extension of unsecured convertible debentures, as initially disclosed in its news releases dated June 10 and 23, 2026.

The company amended the terms of the debentures in the principal amounts of $425,000, $285,000, $1.4-million, $865,000, $1.6-million and $900,000, bearing interest at a rate of 8 per cent per annum, to extend the maturity dates of the debentures by one year to Nov. 12, 2027, Nov. 29, 2027, Dec. 19, 2027, Jan. 14, 2028, Feb. 28, 2028, and March 14, 2028, respectively.

As consideration for the agreement of the debentureholders to extend the maturity dates, the company issued 16.9 million common share purchase warrants of the company to the beneficial holders of the debentures. Each warrant entitles the holder thereof to purchase one common share of the company at an exercise price of 50 cents per share until Aug. 21, 2027.

The warrants, any shares issued upon exercise of the warrants and the conversion of the debentures are subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation.

About Bionxt Solutions Inc.

Bionxt is a bioscience innovator focused on next-generation drug delivery technologies, diagnostic screening systems and active pharmaceutical ingredient development. The company's proprietary platforms -- sublingual (thin-film), transdermal (skin patch) and oral (enteric-coated tablets) -- target key therapeutic areas, including autoimmune diseases, neurological disorders and longevity. With research and development operations in North America and Europe, Bionxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. Bionxt is committed to improving health care by delivering precise, patient-centric solutions that enhance treatment outcomes worldwide. Bionxt is listed on the Canadian Securities Exchange and the OTCQB Markets, and trades in Germany.

We seek Safe Harbor.